Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Management of Unresectable or Metastatic Cutaneous Melanoma

Recorded Presentation from the NCCN Pharmacy Updates: Updates in the Management of Unresectable or Metastatic Cutaneous Melanoma is organized by National Comprehensive Cancer Network (NCCN) and will be held from Jul 05, 2022 - Jun 30, 2023,,Description:,In order to help patients make informed treatment decisions, health care professionals need to understand the clinical data regarding the efficacy and safety of newly approved regimens. In addition, toxicity management, particularly with the oral agents can pose a unique challenge to pharmacists, nurses, and physicians as well as patients and caregivers. The involvement of a multidisciplinary health care team is vital to ensure adequate safety monitoring and management of treatment-related adverse events. Pharmacists play a critical role in patient education, monitoring, and management of treatment-related toxicities and will benefit from a comprehensive review of the novel treatments for cutaneous melanoma.,,Learning Objectives:,Following this activity, participants should be able to:,• Discuss the development of systemic therapy for unresectable and metastatic melanoma over the last decade and its impact on survival outcomes.,• Interpret the evidence and place in therapy for the triplet combination of BRAF/MEK inhibitors with PD-1 blockade for unresectable or metastatic melanoma.,• Outline a treatment monitoring plan for common class-associated and substance-specific BRAF/MEK inhibitor-related toxicities.,,Additional details will be posted as soon as information is available.